The company behind popular weight-loss drugs failed to disclose millions of pounds it paid to healthcare groups and patient ...

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger ...

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...